Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis

Gut

Volumn 53, Issue 5, 2004, Pages 723-728

  Chandak, G R ^a   Idris, M M ^a   Reddy, D N ^b   Mani, K R ^a   Bhaskar, S ^a   Rao, G V ^b   Singh, L ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^b ASIAN INSTITUTE OF GASTROENTEROLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

TRYPSIN INHIBITOR; TRYPSINOGEN;

ADULT; ALCOHOLIC PANCREATITIS; ARTICLE; CHRONIC PANCREATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENDOCRINE DISEASE; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HEREDITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; RELATIVE; STATISTICAL ANALYSIS;

ADULT; CHRONIC DISEASE; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; PANCREATITIS; PEDIGREE; PHENOTYPE; TRYPSIN; TRYPSIN INHIBITOR, KAZAL PANCREATIC; TRYPSINOGEN;

EID: 2342433551     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2003.026526     Document Type: Article

References (49)

1. Ammann RW. Natural history of chronic pancreatitis. Dig Surg 1994;11:267-74.
2. Steer ML, Waxman I, Freedman S. Chronic pancreatitis. N Engl J Med 1995;332:1482-90.
3. Etemad B, Whitcomb DC. Chronic pancreatitis:diagnosis, classification, and new genetic developments. Gastroenterology 2001;120:682-707.
4. Ammann RW. A clinically based classification system for alcoholic chronic pancreatitis: summary of an international workshop on chronic pancreatitis. Pancreas 1997;14:215-21.
5. Kloppel G, Luttges J, Lohr M, et al. Autoimmune pancreatitis: Pathological, clinical and immunological features. Pancreas 2003;27:14-19.
6. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996;14:141-5.
7. Gorry MC, Gabbaizedeh D, Furey W, et al. Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology 1997;113:1063-8.
8. Witt H, Luck W, Becker M. A signal peptide deavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology 1999;117:7-10.
9. Teich N, Ockenga J, Hoffmeister A, et al. Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation. Gastroenterology 2000;119:461-5.
10. Ferec C, Roguenes O, Salomon R, et al. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis. J Med Genet 1999;36:228-32.
11. Le Marechal C, Chen JM, Quere I, et al. Discrimination of three mutational events that result in a disruption of the R122 primary autolysis site of the human cationic trypsinogen (PRSS1) by denaturing high performance liquid chromatography. BMC Genet 2001;2:19.
12. Pfutzer R, Myers E, Applebaum-Shapiro S, et al. Novel cationic trypsinogen (PRSS1) N29T and R122C mutations cause autosomal dominant hereditary pancreatitis. Gut 2002;50:271-2.
13. Witt H, Luck W, Hennies HC, et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000;25:213-16.
14. Pfutzer RH, Whitcomb DC. Trypsinogen mutations in chronic pancreatitis. Gastroenterology 1999;117:1507-8.
15. Chen JM, Raguenes O, Ferec C, et al. A CGC>CAT gene conversion-like event resulting in the R122H mutation in the cationic trypsinogen gene and its implication in the genotyping of pancreatitis. J Med Genet 2000;37:E36.
16. Monaghan KG, Jackson CE, KuKuruga DL, et al. Mutation analysis of the cystic fibrosis and cationic trypsinogen genes in patients with alcohol-related pancreatitis. Am J Med Genet 2000;94:120-4.
17. Chandak GR, Idris MM, Reddy DN, et al. Mutations in the pancreatic secretory trypsin inhibitor gene (PSTI/SPINK1) rather than the cationic trypsinogen gene (PRSS1) are significantly associated with tropical calcific pancreatitis. J Med Genet 2002;39:347-51.
18. Mohan V, Chari ST, Hitman GA, et al. Familial aggregation in tropical fibrocalculous pancreatic diabetes. Pancreas 1989;4:690-3.
19. Pfutzer RH, Barmada MM, Brunskill APJ, et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000;119:615-23.
20. Chan JM, Mercier B, Audrezet MP, et al. Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis. J Med Genet 2000;37:67-9.
21. Kaneko K, Nagasaki Y, Furukuwa T, et al. Analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene mutations in Japanese patients with chronic pancreatitis. J Hum Genet 2001;46:293-7.
22. Ockenga J, Dork T, Stuhrmann M. Low prevalence of SPINK1 gene mutations in adult patients with chronic idiopathic pancreatitis. J Med Genet 2001;38:243-4.
23. Bisceglie AM, Segal I. Cirrhosis and chronic pancreatitis in alcoholics. J Clin Gasteroenterol 1984;6:199-200.
24. Witt H, Luck W, Becker M, et al. Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis. JAMA 2001;285:2716-17.
25. Horii A, Kobayashi T, Tomito N, et al. Primary structure of human pancreatic secretory trypsin inhibitor (PSTI) gene. Biochem Biophys Res Commun 1987;149:635-41.
26. Bhatia E, Choudhuri G, Sikora SS, et al. Tropical calcific pancreatitis:strong association with SPINK1 trypsin inhibitor mutations. Gastroenterology 2002;123:1020-5.
27. The Expert Committee an the Diagnosis and Clasiffication of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
28. Perrault J. Hereditary pancreatitis. Gastroenterol Clin North Am 1994;23:743-52.
29. Threadgald J, Greenhalf W, Ellis I, et al. The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut 2002;50:675-81.
30. Drenth JP, te Morsche R, Jansen JB. Mutations in serine protease inhibitor Kozal type 1 are strongly associated with chronic pancreatitis. Gut 2002;50:687-92.
31. Pfutzer RH, Whitcomb DC. SPINK 1 mutations are associated with multiple phenotypes. Pancreatology 2001;1:457-60.
32. Dasouki MJ, Cogan J, Summar ML, et al. Heterogeneity in hereditary pancreatitis. Am J Med Genet 1998;77:47-53.
33. Creighton J, Lyall R, Wilson DI, et al. Mutations of the cationic trypsinogen gene in patients with chronic pancreatitis. Lancet 1999;354:42-3.
34. Nishimori I, Kamakura K, Fujikawa-Adachi K, et al. Mutations in exon 2 and 3 of the cationic trypsinogen gene in Japanese families with hereditary pancreatitis. Gut 1999;44:259-63.
35. Hassan Z, Mohan V, Ali I, et al. SPINK1 is a susceptibility gene for fibrocalculous pancreatic diabetes in subjects from the Indian subcontinent. Am J Hum Genet 2002;71:964-6.
36. Witt H. Gene mutations in children with chronic pancreatitis. Pancreatology 2001;1:432-8.
37. Chen JM, Mercier B, Audrezet MP, et al. Mutations of the pancreatic secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis. Gastroenterology 2001;120:1061-2.
38. Truninger K, Witt H, Kock, et al. Mutations of the serine protease inhibitor, Kazal type 1 gene, in patients with idiopathic chronic pancreatitis. Am J Gastroenterol 2002;97:1133-7.
39. Rinderknecht H, Stace NH, Renner IG. Effects of chronic alcohol abuse on exocrine pancreatic secretion in man. Dig Dis Sci 1985;30:65-71.
40. Gukovskaya AS, Mouria M, Gukovsky I, et al. Ethanol metabolism and transcripton factor activation in pancreatic acinar cells in rats. Gastroenterology 2002;122:106-18.
41. Lowenfels AB, Maisonneuve P, Grover H, et al. Racial factors and the risk of chronic pancreatitis. Am J Gastroenterology 1999;94:790-4.
42. Hirota M, Kuwata K, Ohmuroya M, et al. From acute to chronic pancreatitis: The role of mutations in the pancreatic secretory trypsin inhibitor gene. J Pancreas 2003;4:83-8.
43. Sharer N, Schwarz M, Malane G, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998;339:645-52.
44. Cohn JA, Friedman KJ, Noone PG, et al. Relation between mutations of the cystic fibrosis gene and-idiopathic pancreatitis. N Engl J Med 1998;339:653-8.
45. Noone PG, Zhou Z, Silverman LM, et al. Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 2001;121:1310-9.
46. Witt H, Kage A, Luck W, et al. Alpha 1-antitrypsin genotypes in patients with chronic pancreatitis. Scand J Gastroenterol 2002;37:356-9.
47. Teich N, Walther K, Bodeker H, et al. Relevance of variants in serum antiproteinases for the course of chronic pancreatitis. Scand J Gastroenterol 2002;37:360-5.
48. Audrezet MP, Chen JM, Le Marechal C, et al. Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis. Eur J Hum Genet 2002;10:100-6.
49. Perri F, Piepoli A, Andriulli A. On the role of CFTR, PRSS1 and PST1/SPINK1 in idiopathic chronic pancreatitis. Eur J Hum Genet 2003;11:107.